News Sanofi

Equities

SAN

FR0000120578

Real-time Euronext Paris Other stock markets 07:18:59 2024-05-08 am EDT			5-day change	1st Jan Change
93.53 ^EUR	+1.80%		+1.75%	+4.18%

May. 07	Sanofi Close to Choosing BNP, BofA for Consumer Health Spinoff Deal	MT
May. 06	Bank of America, BNP Set to Win Lead Roles on Sanofi's Consumer-Healthcare Spin Off	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sanofi Close to Choosing BNP, BofA for Consumer Health Spinoff Deal	May. 06	MT
Bank of America, BNP Set to Win Lead Roles on Sanofi's Consumer-Healthcare Spin Off	May. 06	MT
Sector Update: Financial Stocks Higher Monday Afternoon	May. 06	MT
Bank of America, BNP Set to Win Lead Roles on Sanofi's Consumer-Healthcare Spin Off	May. 06	MT
Bank of America, BNP Set to Win Lead Roles on Sanofi's $20 Billion Consumer Healthcare Spin Off, Bloomberg Reports	May. 06	MT
SANOFI : Buy rating from UBS	May. 06	ZD
GSK plc : Back on track	May. 03
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading	May. 02	MT
Sanofi: new positive data for Beyfortus	May. 02	CF
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations	May. 02	GL
Press Release: Annual General Meeting of April 30, 2024	Apr. 30	GL
Sanofi Announces Board and Committee Appointments	Apr. 30	CI
Sanofi Approves Ordinary Annual Dividend for the Fiscal Year 2023, Payable on May 15, 2024	Apr. 30	CI
European Equities Traded in the US as American Depositary Receipts Decline	Apr. 30	MT
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024	Apr. 30	AQ
SANOFI : Jefferies reiterates its recommendation on the stock	Apr. 29	CF
SANOFI : Deutsche Bank gives a Sell rating	Apr. 29	ZD
SANOFI : JP Morgan remains Neutral	Apr. 29	ZD
Media Update: New data presented at ATS demonstrate Sanofi’s leadership in advancing potential new therapies for patients with immune-mediated respiratory diseases	Apr. 26	PU
Sanofi Q1 robust 7% sales growth driven by launches, underpins full-year guidance	Apr. 26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANOFI : Sanofi’s healthy Q1 performance hailed by markets

April 25, 2024 at 07:58 am EDT

Sanofi Sees Trend for Years of Steady Growth: CFO

February 03, 2023 at 03:56 pm EST